2026-06-14T03:53:30Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/117872025-04-25T08:58:51Zcom_20.500.12105_2052com_20.500.12105_2051com_20.500.12105_15322col_20.500.12105_19609col_20.500.12105_16970

00925njm 22002777a 4500 dc Fernández, André Renaldo author Sanchez-Tarjuelo, Rodrigo author Cravedi, Paolo author Ochando, Jordi author Lppez-Hoyos, Marcos author 2020-11-13 Thanks to the development of new, more potent and selective immunosuppressive drugs together with advances in surgical techniques, organ transplantation has emerged from an experimental surgery over fifty years ago to being the treatment of choice for many end-stage organ diseases, with over 139,000 organ transplants performed worldwide in 2019. Inherent to the transplantation procedure is the fact that the donor organ is subjected to blood flow cessation and ischemia during harvesting, which is followed by preservation and reperfusion of the organ once transplanted into the recipient. Consequently, ischemia/reperfusion induces a significant injury to the graft with activation of the immune response in the recipient and deleterious effect on the graft. The purpose of this review is to discuss and shed new light on the pathways involved in ischemia/reperfusion injury (IRI) that act at different stages during the donation process, surgery, and immediate post-transplant period. Here, we present strategies that combine various treatments targeted at different mechanistic pathways during several time points to prevent graft loss secondary to the inflammation caused by IRI. Int J Mol Sci . 2020 Nov 13;21(22):8549. 10.3390/ijms21228549 1422-0067 International journal of molecular sciences 33202744 http://hdl.handle.net/20.500.12105/11787 RNA interference Cell death Cell metabolism Hypoxia Innate immunity Ischemia reperfusion injury Review: Ischemia Reperfusion Injury-A Translational Perspective in Organ Transplantation